• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

Chagas Disease Screening for Family Members of Positive Blood Donors

April 10, 2019

Chagas disease (CD) is a zoonotic infection caused by blood sucking Trypanosoma cruzi—a parasite that infects over 6 million people in the Americas, including at least 300,000 in the United States.  Transmission can also occur via blood transfusions, organ transplants, or via mother-to-child transmission.  Antitrypanosomal drugs given early can cure the disease, but CD that is left untreated often leads to heart failure.  Since the infection may be asymptomatic, many cases of CD are not treated.  In the United States, less than 1% of infected individuals have been diagnosed and treated.  Since family members of infected individuals often share risk factors for CD, researchers in Los Angeles assessed the prevalence of CD among 189 family members of 86 infected blood donors.  Overall, 7.4% (14/189) of these family members were positive for CD.  Although blood donations have been screened for CD in the US since 2007, further screening of family members of infected donors may be beneficial in identifying new cases.

Reference:

Hernandez S, Forsyth CJ, Flores CA, and SK Meymandi. Prevalence of Chagas disease among family members of previously diagnosed patients in Los Angeles, California. Clinical Infectious Disease 2019

Filed Under

  • Blood Donation
  • News
  • Transfusion Transmitted Infections

Recommended

  • Increasing Data Available for Plasma Transfusion Indications

  • FDA Issues Emergency Use Authorization for COVID-19 Convalescent Plasma

  • FDA Approves Babesia microti Screen for Plasma and Whole Blood Donations

Show Comments

Comments on this article are closed.

Get the latest news. Subscribe to our mailing list. Sign Up

Primary Sidebar

Latest News

  • Nipocalimab for Severe Hemolytic Disease of the Fetus and Newborn

  • Clinical Guidelines for Anemia and Chronic Kidney Disease

  • Ferritin-Guided Donation Policies Decrease Iron Deficiency

  • RBC Transfusions to Treat Acute Heavy Menstrual Bleeding

    Question of the Day

    Copyright © 2026 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley